EFTA Document EFTA01482186
Due Diligence Report N A Property Inc JP Morgan Chase EFTA01482186 Executive Summary On 02/04/2010, GS&I was requested by PCS Front Officeto conduct a background investigation. Media research was conducted on Jeffrey Epstein and Leslie Wexner. Throughout this search, the following records were researched: CSSS/FPS internal database search (JPMorgan Chase Fraud Prevention List Review), publications, regulatory sanctions and OFAC (Office of Foreign Asset Control). Please Note: All rese
Summary
Due Diligence Report N A Property Inc JP Morgan Chase EFTA01482186 Executive Summary On 02/04/2010, GS&I was requested by PCS Front Officeto conduct a background investigation. Media research was conducted on Jeffrey Epstein and Leslie Wexner. Throughout this search, the following records were researched: CSSS/FPS internal database search (JPMorgan Chase Fraud Prevention List Review), publications, regulatory sanctions and OFAC (Office of Foreign Asset Control). Please Note: All rese
Ask AI About This Document
Extracted Text (OCR)
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
24962074881391659800874201069790108ReferenceLink to Specific Page
Share a direct link to a specific page in this document:
https://epsteinexposed.com/documents/sd-10-EFTA01482186?page=[page_number]Related Documents (6)
EFTA01682184
EFTA01370863
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
EFTA00014087
EFTA02367961
EFTA01977826
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.